Shifting Treatment Paradigms in Non-Hodgkin Lymphomas
Despite significant therapeutic advances in the treatment of patients with non-Hodgkin lymphoma (NHL), a significant proportion experience relapse or progression following standard immunochemotherapy (ICT). The introduction of novel targeted immunotherapy agents has potentially ushered in a new era...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2017-08-01
|
| Series: | European Medical Journal Hematology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/hematology/symposium/shifting-treatment-paradigms-in-non-hodgkin-lymphomas/ |